.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer last year for an enormous $43 ...
.On the heels of a stage 3 succeed that stopped working to blow away clients, Ironwood Pharmaceutica...
.Don't cease Monte Rosa Therapies right now. The Boston-based biotech is having a ball after authori...
.Accept to today's Chutes & Ladders, our roundup of considerable leadership hirings, shootings an...
.Celebrating his provider's upsized going public (IPO), Septerna CEO Jeffrey Finer called the openin...
.AbbVie has come back to the source of its antipsychotic powerhouse Vraylar looking for another runa...
.GenSight Biologics is full weeks out of losing cash. Once again. The biotech simply possesses adequ...
.Monopar Rehabs is bouncing back a medicine from the scrap heap of AstraZeneca's unusual health cond...
.With brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one team of analyst...
.After creating a genetics treatment relationship with Dyno Rehabs in 2020, Roche is back for more.I...